GI E2 Flashcards
NSAIDs that put at risk of NSAID PUD
non selective NSAIDS
Non selective NSAID some examples
Naproxen
Ibuprofen
Aspirin
Selective COX 2 NSAIDs
Celecoxib (Celebrex)
Nabumetone
Meloxicam
Etodolac
NSAID PUD Risk factors
Age > 65 years old
Previous hx of an ulcer
Steroid concomitant use
Nonselective NSAID
High dose of NSAID
Multiple NSAIDs (Ibu + ASA)
Anticoagulant use
Antiplatelet use
PPI Examples
Omeprazole
Lansoprazole
Rabeprazole
Pantoprazole
Esomeprazole
Dexlansoprazole
Antacids
Sodium bicarbonate
H2RA Antagonists
Cimetidine
Famotidine
Nizatidine
Mucosal Protectants
Sucralfate
Misoprostol
5-Aminosalicylates (5ASA) Examples
Mesalamine
Olsalazine
Balsalazide
Sulfasalazine
Immunomodulators Examples
Azathioprine
6-Mercaptopurine
Methotrexate
Cyclosporine
Antibiotics Examples
Metronidazole
Ciprofloxacin
Corticosteroids Examples
Budesonide
Prednisone
Methylprednisolone
Hydrocortisone
Biologics Examples
Anti-TNF alpha:
Infliximab
Adalimumab
Certolizumab
Golimumab
Selective Adhesion Molecule (Integrin) inhibitor:
Natalizumab
Vedolizumab
IL Inhibitors:
Ustekinumab
Risankizumab
JAK inhibitors
Tofacitinib
Upadacitinib
Sphingosine 1 - Phosphate (SIP) Receptor Modulator
Ozanimod
IV IBD Drugs
Methylprednisolone
Hydrocortisone
Infliximab
Natalizumab
Vedolizumab
Ustekinumab then SC
Risankizumab then SC
PO IBD Drugs
Mesalamine
Olsalazine
Balsalazide
Sulfasalazine
Azathioprine
6-MP
Methotrexate
Cyclosporine
Prednisone
Budesonide
Tofacitinib
Upadacitinib
Ozanimod
Mobs cammp but o
SQ IBD Drugs
Methotrexate
Adalimumab
Certolizumab
Golimumab
Ustekinumab is first IV then SC
Risankizumab is first IV then SC
UR c mag
Mod Severe Active CD Biologics
Infliximab
Adalimumab
Natalizumab
Certolizumab
Ustekinumab
Risankizumab
Vedolizumab
I an curv
Mod Severe Active UC Biologics
Infliximab
Golimumab
Adalimumab
Vedolizumab
Ustekinumab
I Gavu
Entocort
Budesonide for CD
Uceris
Budesonide for UC
Rowasa
Mesalamine products (enema) to rectum and distal colon
Cauasa
Mesalamine products (supp) to rectum only
